Transgenic mouse models of Alzheimer's disease

Physiology and Behavior

Volumn 73, Issue 5, 2001, Pages 873-886

  Janus, Christopher ^a   Westaway, David ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Behavior; Cognition; Transgenic mouse; Amyloid

Indexed keywords

AGING; ALLELE; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL MODEL; COGNITION; COGNITIVE DEFECT; DISEASE MODEL; FAMILIAL DISEASE; GENE EXPRESSION; GENE OVEREXPRESSION; MOLECULAR DYNAMICS; MOUSE STRAIN; NEUROPATHOLOGY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE; TRANSGENIC ANIMAL;

EID: 0034837627     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(01)00524-8     Document Type: Article

References (135)

1. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
2. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
3. The human life span: Are we reaching the outer limits?
4. The aging of the human species
5. Cognitive and neurobiologic markers of early Alzheimer's disease
6. Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease
7. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
8. Life and death of neurons in the aging brain
9. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
10. Alzheimer's disease: Cell-specific pathology isolates the hippocampus formation
11. Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment
12. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia
13. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain
14. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease
15. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease
16. Pathology of Alzheimer's disease
17. Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein
18. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
19. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
20. Microtubule-associated protein tau A component of Alzheimer paired helical filaments
21. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology
22. Alzheimer's disease: Genotypes, phenotypes, and treatments
23. Transgenic mouse models of Alzheimer's disease
24. APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology
25. Transgenic mice expressing Alzheimer amyloid precursor proteins
26. Transgenic animals relevant to Alzheimer's disease
27. Alzheimer's disease: Genetic studies and transgenic models
28. Mutant genes in familial Alzheimer's disease and transgenic models
29. What transgenic mice tell us about neurodegenerative disease
30. Single and multiple transgenic mice as models for Alzheimer's disease
31. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
32. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
33. Brain trauma in aged transgenic mice induces regression of established abeta deposits
34. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease
35. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
36. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
37. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
38. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
39. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging
40. A beta40 is a major form of beta-amyloid in nonhuman primates
41. Beta-amyloid (A beta) deposition in the brains of aged orangutans
42. Senile plaques in cortex of aged normal monkeys
43. The neural basis of memory decline in aged monkeys
44. Identification of amyloid-beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus
45. Animal models of cerebral beta-amyloid angiopathy
46. β-Amyloid accumulation correlates with cognitive dysfunction in the aged canine
47. The canine as an animal model of human aging and dementia
48. Visual-discrimination learning ability and beta-amyloid accumulation in the dog
49. Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains
50. Diffuse plaques contain C-terminal A beta 42 and not A beta 40: Evidence from cats and dogs
51. Neurofibrillary tangles and senile plaques in aged bears
52. Age-associated inclusions in normal and transgenic mouse brain
53. Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice
54. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
55. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
56. Correlative memory deficits, a-beta elevation, and amyloid plaques in transgenic mice
57. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis
58. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
59. The older rabbit as an animal model: Implications for Alzheimer's disease
60. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: Implications of genetic background for single gene mutations and quantitative trait loci analyses
61. Behavioral dissociations between C57bl-6 and Dba-2 mice on learning and memory tasks - A hippocampal-dysfunction hypothesis
62. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning
63. Gene-targeting studies: New methods, old problems
64. Gene-targeting studies of mammalian behavior is it the mutation or the background genotype?
65. Lung disease in mice with cystic fibrosis
66. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
67. Genetic modification of presenilin 1 deficiency in mice by distal chromosome 1
68. Canalization: A molecular genetic perspective
69. Challenges to a science of developmental psychology
70. A proposed test battery and constellation of specific behavioural paradigms to investigate the behavioural phenotypes of transgenic and knockout mice
71. Amyloid, the presenilins and Alzheimer's disease
72. Intrahippocampal injections of the beta-amyloid 1-28 fragment induces behavioral deficits in rats
73. Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency
74. Beta-amyloid(1-40) effects on behavior and memory
75. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat
76. Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system
77. Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42)
78. Beta-amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: Behavioral, neurochemical and histological effects
79. A vector for expressing foreign genes in the brains and hearts of transgenic mice
80. Expression of APP in brains of transgenic mice containing the entire human APP gene
81. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
82. Transgenic mouse brain histopathology resembles early Alzheimer's disease
83. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1
84. Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain
85. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice
86. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice
87. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice
88. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease
89. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein
90. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein
91. Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo
92. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein
93. Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein
94. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits
95. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease
96. Lack of β-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations
97. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
98. Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene
99. Mice homozygous for a modified beta-amyloid precursor protein (beta-app) gene show impaired behavior and high-incidence of agenesis of the corpus-callosum
100. Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified beta-amyloid precursor protein gene
101. Assessing the effects of the 129/Sv genetic background on swimming navigation learning in transgenic mutants: A study using mice with a modified beta-amyloid precursor protein gene
102. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory
103. Aging and the physiology of spatial memory
104. The importance of comparative studies and ecological validity for understanding hippocampal structure and cognitive function
105. A synaptic model of memory: Long-term potentiation in the hippocampus
106. Hippocampal mossy fiber distribution covaries with open-field habituation in the mouse
107. Animal-models of normal aging - Relationship between cognitive decline and markers in hippocampal circuitry
108. Neural subsystems of exploration in rats
109. Toward a representational hypothesis of the role of hippocampal synaptic plasticity in spatial and other forms of learning
110. Hippocampus space and memory
111. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans
112. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
113. FVB/N: An inbred mouse strain preferable for transgenic analysis
114. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
115. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease
116. Development of place navigation in rats from weaning to puberty
117. Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool
118. Visits to starts, routes, and places by rats (Rattus norvegicus) in swimming pool navigation tasks
119. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation
120. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs
121. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice
122. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
123. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein
124. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice
125. Expression of APP in transgenic mice: A comparison of neuron-specific promoters
126. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
127. Neuron loss in APP transgenic mice
128. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751
129. Behavioural despair in rats: A new model sensitive to antidepressant treatments
130. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes
131. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
132. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
133. Genetics of mouse behavior: Interactions with laboratory environment